Novel Potent Opioids Require Higher Number of Naloxone Doses Than Fentanyl
Researchers examined the naloxone administration and clinical outcomes of patients experiencing overdose from novel potent opioids, compared with fentanyl alone.
Diagnosis & Disease Information
High-Quality Evidence Lacking for Nondrug Treatments in Psoriatic Arthritis
Investigators assessed how the outcomes of patients with psoriatic arthritis may be improved using lifestyle modifications and nonpharmacologic and psychological interventions.
Oral Microbiota Therapeutic Reduces CDI Recurrence in High-Risk Patients
Researchers investigated the efficacy of an oral microbiota therapeutic against recurrent Clostridioides difficile infection across high-risk subgroups.
Soy-Based Products Have Useful Dermatologic Applications
Investigators sought to evaluate the effects of soy supplementation or topical application on dermatologic outcomes.
Updated Guidelines for Combined Oral Contraceptives for PCOS
Investigators assessed the use of different combined oral contraceptive pills for the treatment and management of polycystic ovary syndrome, as an update to recent evidence-based guidelines.
Higher Oral Semaglutide Doses Superior for Reducing HbA1c and Bodyweight
Efficacy, safety, and tolerability of higher investigational doses of oral semaglutide vs the standard 14-mg dose were evaluated among patients with inadequately controlled type 2 diabetes.
Allergens in Popular Hair Products May Cause Allergic Contact Dermatitis
Investigators reviewed allergens, common hair care practices, and hair care product ingredients that may trigger allergic contact dermatitis of the scalp, face, and neck.
Oral JAK Inhibitors Resulted in Hair Regrowth for Patients With Alopecia Areata
Investigators aimed to assess the efficacy and safety of JAK inhibitors for the treatment of alopecia areata.
Biologics May Cause Significant Weight Gain in Men With Psoriasis
Researchers sought to characterize the treatment effects of biologic agents on obesity-related disorders, body weight, and metabolic risk factors in patients with moderate to severe psoriasis.
Semaglutide and Phentermine/Topiramate Linked to Greatest Body Weight Reduction
Researchers examined the safety and efficacy of several weight loss drugs approved for the management of obesity.
- Loading...
Loading...
Loading... 
Loading...